MarPam Pharma LLC

Recombinetics, based in Saint Paul, MN, is a recognized leader in animal gene editing for biomedical research and animal agriculture. The company specializes in providing custom gene-edited swine models for translational preclinical research, aiming to expedite the regulatory preclinical path while reducing reliance on nonhuman primates. With a mission to elevate biomedical innovation, Recombinetics employs state-of-the-art breeding methods to enhance the health, welfare, and sustainability of food animals. Their commitment to integrity and relationships drives their efforts to produce healthier, happier animals that contribute to sustainable farming practices. Generated from the website

InSitu Biologics, Inc. is an emerging biotech company based in St. Paul, MN, dedicated to developing a multiphase prolonged release drug delivery platform aimed at localized treatment for pain, cancer, and infection. The company employs disruptive technology to address unmet needs in the pain management and drug delivery markets. Currently in the investigational preclinical stage, InSitu Biologics is advancing two key products: INSB200, an extended release solution for perioperative pain management, and INSB400, an early development product designed for the local delivery of cancer drugs with a precise elution rate. These innovative solutions represent a multibillion-dollar opportunity as the company approaches Phase 1 clinical trials. Generated from the website

Grip Molecular Technologies Inc is a biotechnology company based in Saint Paul, MN. Specializing in molecular research and development, the company focuses on innovative solutions for various industries. With a team of skilled scientists and cutting-edge technology, Grip Molecular Technologies Inc is dedicated to advancing scientific knowledge and pushing the boundaries of molecular technology. Generated from their business information